SUBSCRIBE
SUBSCRIBE
EXPLORE +
  • About infoDOCKET
  • Academic Libraries on LJ
  • Research on LJ
  • News on LJ
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Libraries
    • Academic Libraries
    • Government Libraries
    • National Libraries
    • Public Libraries
  • Companies (Publishers/Vendors)
    • EBSCO
    • Elsevier
    • Ex Libris
    • Frontiers
    • Gale
    • PLOS
    • Scholastic
  • New Resources
    • Dashboards
    • Data Files
    • Digital Collections
    • Digital Preservation
    • Interactive Tools
    • Maps
    • Other
    • Podcasts
    • Productivity
  • New Research
    • Conference Presentations
    • Journal Articles
    • Lecture
    • New Issue
    • Reports
  • Topics
    • Archives & Special Collections
    • Associations & Organizations
    • Awards
    • Funding
    • Interviews
    • Jobs
    • Management & Leadership
    • News
    • Patrons & Users
    • Preservation
    • Profiles
    • Publishing
    • Roundup
    • Scholarly Communications
      • Open Access

July 9, 2021 by Gary Price

FiveThirtyEight on “How Science Moved Beyond Peer Review During the Pandemic”

July 9, 2021 by Gary Price

From FiveThirtyEight:

He [Dr. Eric Rubin, editor in chief of the New England Journal of Medicine] and other scientists said the issue of speed was particularly important for clinical research during the pandemic because doctors needed the most up-to-date information to make life-saving decisions for critically ill patients. For example, the large trial of the steroid dexamethasone — which first demonstrated that this cheap, widely available drug could reduce the likelihood of death in COVID-19 patients — was originally posted as a preprint. It would show up, traditionally published, in the New England Journal of Medicine eight months later, but the preprint made it possible to get that knowledge into doctors’ hands faster. “I had one MD who contacted me, and he said, ‘You know, there are probably people who are alive today who would have been dead if not for preprints,’” [Richard] Sever [the co-founder of bioRxiv and medRxiv] said.

Processes like that have contributed to making preprints more widely accepted among biological and medical scientists. It also helps that research in preprints isn’t a lot different statistically from how those same papers eventually end up being published in a peer-reviewed scientific journal. A 2020 study of pre-COVID-19 bioscience that compared preprint papers and their later, peer-reviewed versions, for example, found that the biggest differences were in details like how clearly the title reflected the conclusions or how easy it was to find relevant information in the article.

But that should be understood as a critique of the peer-review process rather than a glowing endorsement of preprint paper accuracy, said Alice Fleerackers, a graduate student and researcher at the Scholarly Communications Lab, a joint project of the Simon Fraser University and University of Ottawa. “There’s really a perception that peer review is a trustworthy quality-control mechanism,” Fleerackers said. But research hasn’t been able to support that idea. All the jokes and paranoia about COVID-19 being spread by 5G cellphone technology, for instance, trace their origin to a paper published in — and later retracted by — a scientific journal that claims to peer-review its content.

Read the Complete Article (approx. 1310 words)

Filed under: Journal Articles, News, Scholarly Communications

SHARE:

About Gary Price

Gary Price (gprice@gmail.com) is a librarian, writer, consultant, and frequent conference speaker based in the Washington D.C. metro area. He earned his MLIS degree from Wayne State University in Detroit. Price has won several awards including the SLA Innovations in Technology Award and Alumnus of the Year from the Wayne St. University Library and Information Science Program. From 2006-2009 he was Director of Online Information Services at Ask.com.

ADVERTISEMENT

Archives

Job Zone

ADVERTISEMENT

Related Infodocket Posts

ADVERTISEMENT

FOLLOW US ON X

Tweets by infoDOCKET

ADVERTISEMENT

This coverage is free for all visitors. Your support makes this possible.

This coverage is free for all visitors. Your support makes this possible.

Primary Sidebar

  • News
  • Reviews+
  • Technology
  • Programs+
  • Design
  • Leadership
  • People
  • COVID-19
  • Advocacy
  • Opinion
  • INFOdocket
  • Job Zone

Reviews+

  • Booklists
  • Prepub Alert
  • Book Pulse
  • Media
  • Readers' Advisory
  • Self-Published Books
  • Review Submissions
  • Review for LJ

Awards

  • Library of the Year
  • Librarian of the Year
  • Movers & Shakers 2022
  • Paralibrarian of the Year
  • Best Small Library
  • Marketer of the Year
  • All Awards Guidelines
  • Community Impact Prize

Resources

  • LJ Index/Star Libraries
  • Research
  • White Papers / Case Studies

Events & PD

  • Online Courses
  • In-Person Events
  • Virtual Events
  • Webcasts
  • About Us
  • Contact Us
  • Advertise
  • Subscribe
  • Media Inquiries
  • Newsletter Sign Up
  • Submit Features/News
  • Data Privacy
  • Terms of Use
  • Terms of Sale
  • FAQs
  • Careers at MSI


© 2026 Library Journal. All rights reserved.


© 2022 Library Journal. All rights reserved.